A detailed history of Canopy Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Canopy Partners, LLC holds 4,983 shares of AZN stock, worth $330,372. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,983
Previous 5,759 13.47%
Holding current value
$330,372
Previous $449 Million 13.56%
% of portfolio
0.17%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$76.67 - $87.62 $59,495 - $67,993
-776 Reduced 13.47%
4,983 $388 Million
Q2 2024

Aug 09, 2024

BUY
$66.81 - $80.83 $66,542 - $80,506
996 Added 20.91%
5,759 $449 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $58,527 - $66,717
959 Added 25.21%
4,763 $323 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $235,429 - $263,541
3,804 New
3,804 $256 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Canopy Partners, LLC Portfolio

Follow Canopy Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canopy Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canopy Partners, LLC with notifications on news.